Socioeconomic Impact of Immunoglobulin Replacement Therapy for Primary Immunodeficiency Patients on the Health Public System in Brazil: A Single Center Study

Abstract

The cost of Teriflunomide treatment for RRMS patients is higher and costing the health plan around $3552 per month. The cost of the drug treatment was higher in southern of the USA and males were paying more in general. PND6Cost-Utility ANAlysis of NAtAlizUmAb As first-liNe treAtmeNt of HigHly-ACtive relAPsiNg-remittiNg mUltiPle sClerosis iN tHe brAziliAN PUbliC HeAltHCAre system

II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies

“… 165 There is a need for training and engagement of patients and/or caregivers, which is usually possible to be achieved over 4 to 6 weeks, and close monitoring of the infusion technique must be maintained subsequently. 27 , 104 , 137 , 162 There are several studies, 31 , 166 - 171 including national studies, 172 pointing to a considerable cost reduction associated with subcutaneous administration, particularly when performed at home.…”